MiR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Fang, Wang ^a   Shu, Shan ^a   Yongmei, Li ^b   Endong, Zhu ^b   Lirong, Yin ^a   Bei, Sun ^b  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MIRN224 MICRORNA, HUMAN; PROTEIN TYROSINE KINASE; RB1CC1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; AUTOPHAGY; BINDING SITE; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PAPILLOMAVIRUS INFECTION; PHYSIOLOGY; RNA INTERFERENCE; UTERINE CERVIX TUMOR; VIROLOGY;

3' UNTRANSLATED REGIONS; AUTOPHAGY; BASE SEQUENCE; BINDING SITES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICRORNAS; PAPILLOMAVIRUS INFECTIONS; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; UTERINE CERVICAL NEOPLASMS;

EID: 84987652919     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33229     Document Type: Article

References (32)

1. Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 136, E359-E386 (2015).
2. Walboomers, J. M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19 (1999).
3. Moody, C. A. & Laimins, L. A. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer. 10, 550-560 (2010).
4. Radley, D., Saah, A. & Stanley, M. Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Hum. Vaccin. Immunother. 12, 768-772 (2016).
5. Munoz, N. et al. Chapter 1: HPV in the etiology of human cancer. Vaccine. 24S3, S1-10 (2006).
6. Li, X. et al. Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis. Int. J. Clin. Exp. Med. 8, 10304-10314 (2015).
7. Sun, K. et al. Paradoxical roles of autophagy in different stages of tumorigenesis: protector for normal or cancer cells. Cell. Biosci. 3, 35-43 (2013).
8. Kudchodkar, S. B. & Levine, B. Viruses and autophagy. Rev. Med. Virol. 19, 359-378 (2009).
9. Frankel, L. B. & Lund, A. H. MicroRNA regulation of autophagy. Carcinogenesis. 33, 2018-2025 (2012).
10. He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531 (2004).
11. Lever, A. M. & Jeang, K. T. Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry. 50, 920-931 (2011).
12. Houzet, L. & Jeang, K. T. MicroRNAs and human retroviruses. Biochim. Biophys. Acta. 1809, 686-693 (2011).
13. Di Leva, G. & Croce, C. M. Roles of small RNAs in tumor formation. Trends. Mol. Med. 16, 257-267 (2010).
14. Wang, X. et al. MicroRNAs are biomarkers of oncogenic human papillomavirus infections. Proc. Natl. Acad. Sci. USA 111, 4262-4267 (2014).
15. Martinez, I. et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene. 27, 2575-2582 (2008).
16. Behrends, C., Sowa, M. E., Gygi, S. P. & Harper, J. W. Network organization of the human autophagy system. Nature. 466, 68-76 (2010).
17. Ichimura, Y. et al. Structural basis for sorting mechanism of p62 in selective autophagy. J. Biol. Chem. 283, 22847-22857 (2008).
18. Hara, T. et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell. Biol. 181, 497-510 (2008).
19. Dikic, I., Johansen, T. & Kirkin, V. Selective autophagy in cancer development and therapy. Cancer. Res. 70, 3431-3434 (2010).
20. Jones, S. A., Mills, K. H. & Harris, J. Autophagy and inflammatory diseases. Immunol. Cell. Biol. 91, 250-258 (2013).
21. Wang, X. et al. Aberrant expression of oncogenic and tumorsuppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One. 3, e2557 (2008).
22. Lui, W. O., Pourmand, N., Patterson, B. K. & Fire, A. Patterns of known and novel small RNAs in human cervical cancer. Cancer. Res. 67, 6031-6043 (2007).
23. White, N. M. et al. Three dysregulatedmiRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer. Br. J. Cancer. 102, 1244-1253 (2010).
24. Boguslawska, J. et al. miR-224 targets the 3' UTR of type 1 5'-iodothyronine deiodinase possibly contributing to tissue hypothyroidism in renal cancer. PLoS One. 6, e24541 (2011).
25. Cui, R. et al. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget. 6, 21802-21815 (2015).
26. Shi, K. Q. et al. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Oncotarget. 6, 25093-25108 (2015).
27. Li, M. Y. & Hu, X. X. Meta-analysis of microRNA expression profiling studies in human cervical cancer. Med. Oncol. 32, 169 (2015).
28. Lin, F., Wang, P., Shen, Y. & Xie, X. Upregulation of microRNA-224 sensitizes human cervical cells SiHa to paclitaxel. Eur. J. Gynaecol. Oncol. 36, 432-436 (2015).
29. Shen, S. N. et al.Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer. Diagnostic. Pathology. 8, 69-75 (2013).
30. Jing, Z., Han, W., Sui, X., Xie, J. & Pan, H. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers. Cancer. Lett. 356, 332-338 (2015).
31. Pan, B., Yi, J. & Song, H. MicroRNA-mediated autophagic signaling networks and cancer chemoresistance. Cancer. Biother. Radiopharm. 28, 573-578 (2013).
32. Dall'Arm, iC. et al. The phospholipase D1 pathway modulates macroautophagy. Nat Commun. 1, 142 (2010).